2021
DOI: 10.1016/j.hrthm.2021.06.1192
|View full text |Cite
|
Sign up to set email alerts
|

Aorticorenal ganglion as a novel target for renal neuromodulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“…Direct arterial renal denervation has shown promise as a treatment for resistant hypertension and chronic kidney disease in animal models but showed suboptimal results in human trials (Reetu et al, 2018; Song et al, 2020). Hori et al, (2021) studied the possibility of aorticorenal ganglion block in pigs and found it highly effective. However, their results from two human cadavers do not match what we found other than the vast number of interconnections.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Direct arterial renal denervation has shown promise as a treatment for resistant hypertension and chronic kidney disease in animal models but showed suboptimal results in human trials (Reetu et al, 2018; Song et al, 2020). Hori et al, (2021) studied the possibility of aorticorenal ganglion block in pigs and found it highly effective. However, their results from two human cadavers do not match what we found other than the vast number of interconnections.…”
Section: Discussionmentioning
confidence: 99%
“…The varied results from the clinical trials, has led researchers to investigate the anatomy of the surrounding area as well as the potential of blocking the aorticorenal ganglion instead (Hori et al, 2021; Reetu et al, 2018). A recent study by Hori et al, (2021) investigated the possibility of aorticorenal ganglion ablation as an alternative means of renal denervation in pigs. They found the procedure to be effective yielding better results than direct renal denervation, with few complications.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, the addition of RDN to bilateral cardiac sympathetic denervation also demonstrated efficacy in patients with recalcitrant ventricular tachycardia or fibrillation (VT/VF). 5 Further, in a large animal model of ischemia-induced VT/VF, 6 aortico-renal ganglion ablation reduced the risk of VT/VF compared with sham ablation pigs. These latter studies suggest that the benefits of RDN extend to both atrial and ventricular arrhythmias.…”
Section: Article See P 814mentioning
confidence: 96%
“…[194][195][196] Interestingly, ablation of aorticorenal ganglion or RDN was protective against ventricular arrhythmias and sudden death after myocardial infarction in pigs. 197 A randomized clinical trial also shows the antiarrhythmic effect of RDN on atrial fibrillation. The ERADICATE-AF trial (Renal Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation) has shown that RDN added to pulmonary vein isolation enhanced long-term antiarrhythmic efficacy compared with pulmonary vein isolation alone in hypertensive patients with atrial fibrillation.…”
Section: Renal Afferentsmentioning
confidence: 99%